Skip to content. | Skip to navigation

Home > News > Greater management of hyperglycaemia in patients with acute coronary syndromes needed
Welcome
Please log in or join
Forgotten password?

You cannot invite others to join this network unless you are a member.

 
Document Actions

Greater management of hyperglycaemia in patients with acute coronary syndromes needed

Patients with acute coronary syndromes (ACS) should have their blood glucose levels actively controlled if it is raised on admission to hospital, says NICE.

Hyperglycaemia, an excess of glucose in the blood, is common among people admitted to hospital with a range of conditions encompassed by ACS, such as heart attack and unstable angina.

Patients with hyperglycaemia have a poorer chance of survival and increased complications while in hospital, regardless of whether they have diabetes.

However, guidance published by NICE today states that hyperglycaemia is not being considered as a risk factor for ACS, and frequently remains untreated.

The NICE guideline on hyperglycaemia in acute coronary syndromes covers the role of intensive insulin therapy in managing hyperglycaemia within the first 48 hours in people admitted to hospital.